5-Methylmethiopropamine

5-Methylmethiopropamine
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); UK: Under Psychoactive Substances Act;
Identifiers
	IUPAC name N-methyl-1-(5-methylthiophen-2-yl)propan-2-amine;
CAS Number	1340105-79-4 ;
PubChem CID	64487873;
ChemSpider	46249721;
UNII	ZP92FK3KK5;
Chemical and physical data
Formula	C9H15NS
Molar mass	169.29 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=CC=C(S1)CC(C)NC;
	InChI InChI=1S/C9H15NS/c1-7(10-3)6-9-5-4-8(2)11-9/h4-5,7,10H,6H2,1-3H3; Key:HZICDJQMPRFRKC-UHFFFAOYSA-N;

5-Methylmethiopropamine (5-MMPA, mephedrene) is a stimulant drug which is a ring-substituted derivative of methiopropamine. It is not a substituted cathinone derivative like mephedrone, as it lacks a ketone group at the β position of the aliphatic side chain, but instead more closely resembles substituted amphetamines. It has been sold as a designer drug, first being identified in Germany in June 2020.^[1]^[2]^[3]

References

^ EU Early Warning System Situation Report. Situation report 2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (Report). 10 August 2020.
^ "Info" (PDF). www.aekwien.at. Retrieved 2021-05-13.
^ New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020

[1] EU Early Warning System Situation Report. Situation report 2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (Report). 10 August 2020.

[2] "Info" (PDF). www.aekwien.at. Retrieved 2021-05-13.

[3] New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020

[1]

[2]

[3]

5-Methylmethiopropamine

See also

References